Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Americas

      Bristol-Myers Squibb to Take Part in Deutsche Bank Global Health Care Conference

      Americas
      Bristol-Myers Squibb to Take Part in Deutsche Bank Global Health Care Conference 4/29/15 will take part in the Deutsche Bank Global Health Care Conference on...

      Canada’s Valeant buys Salix for $11bn

      Americas
      Canada-based Valeant Pharmaceuticals International has completed the acquisition of US-based Salix Pharmaceuticals for around $11bn.   Under the deal, Valeant has acquired all outstanding...

      Neurocrine, Mitsubishi Tanabe to develop VMAT2 inhibitor NBI-98854 for movement disorders

      Americas
      US-based Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement with Japanese firm Mitsubishi Tanabe Pharma to develop and commercialize its VMAT2...

      Novartis’s Jadenu receives FDA approval to treat chronic iron overload

      Americas
      Novartis has received approval from the US Food and Drug Administration (FDA) for its Jadenu (deferasirox) tablets to treat patients with chronic iron overload....

      BioCryst gets $35m contract for new Ebola treatment

      Americas
      BioCryst Pharmaceuticals has received a $35m contract to continue developing BCX4430, a drug that has shown early signs of fighting the Ebola virus.  ...

      Signum out-licenses SIG990 to Dermata to develop new topical treatment for rosacea

      Americas
      US-based biotechnology firm Signum Dermalogix has out-licensed SIG990, a new anti-inflammatory compound, to Dermata Therapeutics for the development of a topical product to treat...

      Cipher Pharma buys Canadian rights to novel treatment for psoriasis and RA from Can-Fite Biopharma

      Americas
      Cipher Pharmaceuticals Inc., a rapidly growing specialty pharmaceutical dermatology company, has licensed the Canadian distribution rights to CF101, a novel chemical entity being developed...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.